Avanos Medical, Inc. (AVNS)
Avanos Medical has a market cap or net worth of $1.30 billion. The enterprise value is $1.46 billion.
The next earnings date is Wednesday, May 3, 2023, before market open.
|Estimated Earnings Date||May 3, 2023|
Avanos Medical has 46.60 million shares outstanding. The number of shares has decreased by -3.51% in one year.
|Shares Change (YoY)||-3.51%|
|Shares Change (QoQ)||+0.02%|
|Owned by Insiders (%)||3.01%|
|Owned by Institutions (%)||95.13%|
The trailing PE ratio is 26.29.
The stock's EV/EBITDA ratio is 11.91, with an EV/FCF ratio of 20.44.
|EV / Earnings||28.98|
|EV / Sales||1.79|
|EV / EBITDA||11.91|
|EV / EBIT||19.46|
|EV / FCF||20.44|
The company has a current ratio of 2.69, with a Debt / Equity ratio of 0.22.
|Debt / Equity||0.22|
|Debt / EBITDA||2.28|
|Debt / FCF||3.91|
Return on equity (ROE) is 4.00% and return on invested capital (ROIC) is 10.60%.
|Return on Equity (ROE)||4.00%|
|Return on Assets (ROA)||2.90%|
|Return on Capital (ROIC)||10.60%|
|Revenue Per Employee||$180,022|
|Profits Per Employee||$11,087|
In the past 12 months, Avanos Medical has paid $14.70 million in taxes.
|Effective Tax Rate||22.55%|
Stock Price Statistics
The stock price has decreased by -12.20% in the last 52 weeks. The beta is 0.93, so Avanos Medical's price volatility has been similar to the market average.
|52-Week Price Change||-12.20%|
|50-Day Moving Average||29.27|
|200-Day Moving Average||26.44|
|Average Volume (30 Days)||250,664|
Short Selling Information
The latest short interest is 1.06 million, so 2.28% of the outstanding shares have been sold short.
|Short Previous Month||910,727|
|Short % of Shares Out||2.28%|
|Short % of Float||2.44%|
|Short Ratio (days to cover)||5.02|
In the last 12 months, Avanos Medical had revenue of $820.00 million and earned $50.50 million in profits. Earnings per share was $1.07.
|Earnings Per Share (EPS)||$1.07|
The company has $127.70 million in cash and $280.00 million in debt, giving a net cash position of -$152.30 million or -$3.27 per share.
|Cash & Cash Equivalents||127.70M|
|Net Cash Per Share||-$3.27|
|Equity / Book Value||1.29B|
|Book Value Per Share||27.71|
In the last 12 months, operating cash flow was $90.90 million and capital expenditures -$19.30 million, giving a free cash flow of $71.60 million.
|Operating Cash Flow||90.90M|
|Free Cash Flow||71.60M|
|FCF Per Share||$1.54|
Gross margin is 54.88%, with operating and profit margins of 9.45% and 6.16%.
Dividends & Yields
Avanos Medical does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for Avanos Medical is $29.58, which is 5.68% higher than the current price. The consensus rating is "Sell".
|Price Target Difference||5.68%|
|Revenue Growth Forecast (5Y)||n/a|
|EPS Growth Forecast (5Y)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|